Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Net Asset Quality Index
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Net Asset Quality Index of 37.9% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥8.81 Billion minus total liabilities of CN¥5.47 Billion yields net assets of CN¥3.34 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Fujian Aonong Biological Technology Grou earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Fujian Aonong Biological Technology Group Incorporation Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how Fujian Aonong Biological Technology Group Incorporation Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 37.9%, representing net assets of CN¥3.34 Billion against total assets of CN¥8.81 Billion CNY. See 603363 total equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 603363 market cap.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 41.0% | CN¥3.58 Billion | CN¥8.74 Billion | CN¥5.16 Billion | ▲ +8.8 pp |
| 2024 | 32.2% | CN¥3.06 Billion | CN¥9.51 Billion | CN¥6.44 Billion | ▲ +35.9 pp |
| 2023 | -3.7% | CN¥-503.22 Million | CN¥13.63 Billion | CN¥14.13 Billion | ▼ -22.1 pp |
| 2022 | 18.4% | CN¥3.43 Billion | CN¥18.66 Billion | CN¥15.23 Billion | ▲ +5.6 pp |
| 2021 | 12.8% | CN¥2.19 Billion | CN¥17.10 Billion | CN¥14.91 Billion | ▼ -19.7 pp |
| 2020 | 32.5% | CN¥3.90 Billion | CN¥12.02 Billion | CN¥8.12 Billion | ▲ +6.4 pp |
| 2019 | 26.1% | CN¥1.28 Billion | CN¥4.92 Billion | CN¥3.64 Billion | ▼ -4.4 pp |
| 2018 | 30.5% | CN¥1.01 Billion | CN¥3.31 Billion | CN¥2.30 Billion | ▼ -7.5 pp |
| 2017 | 38.0% | CN¥965.55 Million | CN¥2.54 Billion | CN¥1.57 Billion | ▲ +3.4 pp |
| 2016 | 34.7% | CN¥593.75 Million | CN¥1.71 Billion | CN¥1.12 Billion | ▲ +1.7 pp |
| 2015 | 33.0% | CN¥445.39 Million | CN¥1.35 Billion | CN¥902.85 Million | ▲ +9.8 pp |
| 2014 | 23.2% | CN¥214.94 Million | CN¥926.86 Million | CN¥711.92 Million | ▲ +8.2 pp |
| 2013 | 15.0% | CN¥106.35 Million | CN¥710.45 Million | CN¥604.09 Million | — |